HIV/aids and epigenetic
DOI:
https://doi.org/10.51481/amc.v65i1.1247Keywords:
HIV, AIDS, epigenetic, genesAbstract
Since 1981, over 75 million people have been infected with human immunodeficiency virus. The survival rate of patients with this infection has dramatically increased with the use of antiretroviral therapy, and this therapy significantly reduced the incidence of AIDS defining events. Despite recent progress, neither a cure nor a preventive vaccine against human immunodeficiency virus infection is likely to become available soon. Epigenetics is defined as the study of chemical modifications of intrinsic and extrinsic factors of the genetic code regulating gene expression. Three types of epigenetic markers have been found: DNA methylation, post-translational histone modifications, and non-coding RNA (ncRNA). In this review, we analyzed recent research about the relation between epigenetic mechanisms, the persistence of HIV in host cells, the chronic inflammatory response evoked, the cardiovascular diseases associated and premature aging in this population.
Downloads
References
Joint United Nations Programme on HIV/AIDS (UNAIDS). In Danger: UNAIDS Global AIDS Update 2022. Geneva, 2022. Licence: CC BY-NC-SA 3.0 IGO.
Deeks SG Lewin SR Havlir DV The end of AIDS: HIV Infection as a chronic disease. Lancet 2013; 382:1525-1533. DOI: 10.1016/S0140-6736(13)61809-7
Zicari S, Sessa L, Cotugno N, Rugiero A, Marrocchi E, Concato C. Immune activation, Inflammation, and Non-AIDS Comorbidities in HIV-Infected Patients under Long-Term ART. Viruses. 2019; 11:1-19. DOI:10.3390/v11030200
Hokelle J, Sharma AL, Tyagi M. Combinational Use of Both Epigenetic and Non-Epigenetic Mechanisms to Efficiently Reactivate HIV Latency. Int J Mol Sci. 2021; 22:3697. DOI:10.3390/ijms22073697
Peixoto P, Cartron PF, Serandour AA, Hervouet E. From 1957 to Nowadays: A Brief History of Epigenetics. Int. J. Mol. Sci. 2020; 21:2-18. DOI: 10.3390/ijms21207571
Ganesan A. Epigenetics: the first 25 centuries. Phil Trans R Soc B. 2018; 373:1-4. DOI:10.1098/rstb.2017.0067
Grunau C, Le Luyer J, Laporte M, Joly D. The Epigenetics Dilemma. Genes 2020; 11:1-3. DOI: 10.3390/genes11010023
Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nature Rev | Genetics. 2016; 17:487-500. DOI: 10.1038/nrg.2016.59
Lange UC, Verdikt R, Amina A, Van Lint C. Epigenetic crosstalk in chronic infection with HIV-1. Sem Immunopathol. 2020; 42:187-200. DOI: 10.1007/s00281-020-00783-3
Browne CJ, Godino A, Salery M, Nestler EC. Epigenetic Mechanisms of Opioid Addiction. Biol Psychiatry. 2020; 87:22-33. DOI:10.1016/j.biopsych.2019.06.027
Fischer N. Infection-induced epigenetic changes and their impact on the pathogenesis of diseases. Sem Immunopath. 2020; 42:127-130. DOI:10.1007/s00281-020-00793-1
Svensson JP. Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment Front Cel. Infect Microbiol. 2021; 11:1-8. DOI: 10.3389/fcimb.2021.668637
Milavetz BI, Balakrishnan L. Viral Epigenetics. Methods Mol Biol. 2015; 1238:569-596 DOI: 10.1007/978-1-4939-1804-1_30
Ahlenstiel CH, Symonds G, Kent SJ, Kelleher AD. Block and Lock HIV Cure Strategies to Control the Latent Reservoir. Front Cel Infect Microbiol 2020; 10:1-13.
DOI: 10.3389/fcimb.2020.00424
Zerbato JM, Purves HV, Lewin SR, Rasmussen TA. Between a shock and a hard place: challenges and developments in HIV latency reversal. Curr Opin Virol. 2019; 38:1-9. DOI: 10.1016/j.coviro.2019.03.004
Lewin SR, Rasmussen TA. Kick and kill for HIV latency. Lancet. 2020; 395:844-846. DOI: 10.1016/S0140-6736(20)30264-6
Chougui G, Margottin-Goguet F. HUSH, a Link Between Intrinsic Immunity and HIV Latency. Front Microbiol. 2019; 10:1-17. DOI:10.1007/978-1-4939-1804-1_21
Zhang J, Crumpacker CS. Toward a Cure: Does Host Immunity Play a Role?. mSphere 2017; 2:e00138-17. DOI:10.1128/mSphere.00138-17
Yarchoan R, Uldrick TS. HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018; 378:1029-41. DOI: 10.1056/NEJMra1615896
Hatano Y, Ideta T, Hirata A, Hatano K, Tomita H, Okada H, et al. Virus-Driven Carcinogenesis. Cancers. 2021; 13:2625. DOI:10.3390/cancers13112625
Verma M. Epigenetic Regulation of HIV, AIDS, and AIDS-Related Malignancies. Met Mol Biol. 2015; 1238:381-403. DOI:10.1007/978-1-4939-1804-1_21
Park LS, Tate JP, Sigel K, Brown ST, Crothers K, Gibert C, et al. Association of Viral Suppression with Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans. A Prospective Cohort Study. Ann Intern Med. 2018; 169:87-96. DOI:10.7326/M16-2094
Shah ASV, Stelzle D, Lee KK. Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis Circulation 2018; 138 :1100-1112. DOI:10.1161/CIRCULATIONAHA.117.033369
Zhang W, Song M, Qu J, Liu GH. Epigenetic Modifications in Cardiovascular Aging and Diseases. Circ Res. 2018; 123:773-786. DOI: 10.1161/CIRCRESAHA.118.312497
Ebner B, Chueng T, Martinez CA. Epigenetics, HIV, and Cardiovascular Disease Risk. Curr Probl Cardiol. 2020; 46:1-9. DOI:10.1016/j.cpcardiol.2020.100615
Eckard AR, Eric G, Meissner EG, Singh I, McComsey GA. Cardiovascular Disease, Statins, and HIV. J Infect Dis. 2016; 214:S83-92. DOI:10.1093/infdis/jiw288
Erlandson KM, Maile YK. HIV and Aging: Reconsidering the Approach to Management of Co-Morbidities. Infect Dis Clin North Am. 2019; 33:769-786. DOI:10.1016/j.idc.2019.04.005.
Rodes B, Cadiñanos J, Cantos AE, Rodríguez J, Ramon JR. Ageing and HIV: Challenges and Biomarkers. EBioMedicine. 2022; 77:10389. DOI:10.1016/j. ebiom.2022.103896
Brunet A, Berger SL. Epigenetics of Aging and Aging-related Disease. C J Gerontol A Biol Sci Med Sci. 2014; 69: S17-S20. DOI: 10.1093/gerona/glu042
Sundermann EE, Hussain MA, Moore DJ, Horvath S, Lin DTS, Erin EMS, et al. Inflammation-related genes are associated with epigenetic aging in HIV. J NeuroVirol. 2019; 25:853-865.DOI: 10.1007/s13365-019-00777-4
Lagathu C, Casarez A, Bereziat V, Nasie M, Capea J, Pinti M. Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. AIDS. 2017; 31: S105-S119. DOI: 10.1097/QAD.0000000000001441
Leng SX, Margolick JB. Aging, sex, inflammation, frailty, and CMV and HIV Infections. Cell Immunol. 2020; 348:1-12. DOI: 10.1016/j.cellimm.2019.104024
Horvath S, Lin TS, Kobor MS, Zoller JA, Said JW, Morgello S, et al. HIV, pathology and epigenetic age acceleration in different human tissues. GeroScience 2022; 44:1609-1620. DOI: 10.1007/s11357-022-00560-0
BLoch M, John M, Smith D, Rasmussen TA, Wrigth E. Managing HIV-associated inflammation and ageing in the era of modern ART. HIV Med. 2020; 21: 2-16.
DOI: 10.1111/hiv.12952
Kiplagat J, Tran DA, Njuguna B, Vedanthan R, Triant VA, Vedathan R, et al. How health systems can adapt to a population ageing with HIV and comorbid disease. Lancet HIV 2022; 9: e281-292.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
